Elaris Launches: AI That Already Knows Your Audience
Join 14,000+ on the waitlist or skip the line and get Pro today
- Find your ideal audience. Search first-party, psychology-based data measured from real people by world-class scientists. The data is never scraped, with over 400,000 audiences of brands and interests to choose from.
- Meet and collaborate with live personas. See motivations and ask questions in chat as if your customers were right in front of you.
- Make what wins. Test ads and ideas with synthetic audiences representing your ideal customers. Co-create strategies, creative briefs, hooks, ads, and campaigns that you know will win from the start.
Why it matters: No more guesswork. No more wasted time prompting an LLM to death. Just content and ideas that win with your audience.
"Marketing works when it's simple, human, and tailored to what makes your audience feel something. Elaris gives you that signal instantly," said
Already, 14,000+ people are on the waitlist to try Elaris. But starting today, anyone can skip the line with Elaris Pro and get instant access.
Availability
- Try free: Join the waitlist at elaris.new (coming this fall)
- Go Pro now: Skip the line and start today.
- Book a demo: For enterprise teams, visit
Solsten .io
About
Optional quotes:
"For years, marketers have had to guess what makes audiences tick. With Elaris, we've turned decades of psychological research into something anyone can use instantly. It's like pressing play on audience understanding," said
Beta tester quotes:
"At this rate, this is a no-brainer," said
Press kit: https://drive.google.com/drive/folders/1bK3ml4oKxpHJYDWQg648uaRkzhoD4uMt
Media contact:
+4915753072551
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/elaris-launches-ai-that-already-knows-your-audience-302558671.html
SOURCE Elaris
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- APP Group and Charta Global Strengthen Access to the Sustainable Packaging Market at PPC Spring Meeting 2026
- Enhertu® Plus Pertuzumab Approved in the EU as First New Regimen in More than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer
- Connecting Excellence Group PLC Announces Treasury up By 10 BTC to 72.941 & £655,999 Raised
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share